FREE Account Opening + No Clearing Fees
Loading...
September 25, 2007 - September 28, 2007

Saamya Biotech IPO Latest News Today

Track all the latest updates and news of Saamya Biotech IPO.

  1. saamya biotech india ltd Directors report

    July 2, 2021 9:04:00 AM

    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.

    Published by : India Infoline
  2. Why This Hot Biotech IPO Might Just Be a Winning Bet

    March 15, 2024 9:37:00 AM

    While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.

    Published by : The UBJ on MSN
  3. Weight loss biotech plans IPO as demand builds for anti-obesity treatments

    March 29, 2024 3:30:00 AM

    It has shown the same promise among people with general obesity. The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...

    Published by : The Financial Times
  4. Acelyrin raises $540 million in rare biotech IPO

    May 5, 2023 3:30:00 AM

    The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...

    Published by : pharmaphorum
  5. Why That Hot Biotech IPO Could Be a Winner

    March 14, 2024 2:33:00 PM

    with IPO funding of more than $1.2 billion so far this quarter still far below precrash levels, Jefferies data show. That might be a sign that conditions are ideal for investing in new biotech ...

    Published by : The Wall Street Journal on MSN
  6. Contineum lowers expectations for $110M IPO as J&J-allied biotech goes public

    April 5, 2024 10:30:00 AM

    Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...

    Published by : FierceBiotech
  7. Boundless Bio boldly goes public with $100M IPO

    March 28, 2024 10:40:00 AM

    Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...

    Published by : FierceBiotech
  8. Biotech IPOs bounced back in first quarter, but backlog remains

    April 12, 2024 2:32:00 PM

    The sum is more than three times the $375 million in total proceeds from biotech IPOs in the first quarter last year, and roughly matches the first quarter total in 2020. Six of the nine biotechs ...

    Published by : Yahoo Finance
  9. Beyond the biotech IPO: a brave new world

    October 12, 2023 9:50:00 PM

    After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...

    Published by : Nature
  10. Aardvark Therapeutics gearing up for $200 million IPO

    April 1, 2024 3:30:00 AM

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we learn about how scientists had a happenstance ...

    Published by : STAT
  11. Contineum prices biotech�s latest IPO, raising $110M for neuroinflammatory drugs

    April 4, 2024 3:30:00 AM

    Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...

    Published by : Yahoo Finance
  12. U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

    March 30, 2024 9:30:00 AM

    Three IPOs and one SPAC debuted this past week, while three IPOs submitted initial filings - Boundless Bio, U-BX Technology, Alta Global, and IB Acquisition, respectively. Three IPOs submitted ...

    Published by : Seeking Alpha

Saamya Biotech IPO Alerts

1. Saamya Biotech India Limited IPO - Listing  Friday, October 19, 2007 12:00:00 AM

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

2. Saamya Biotech India Limited IPO Allotment Status  Thursday, October 18, 2007 10:45:00 AM

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

 

3. Saamya Biotech India Limited IPO listing date & info  Thursday, October 18, 2007 8:36:00 AM

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

4. Saamya Biotech India Limited IPO - Allotment  Thursday, October 18, 2007 12:00:00 AM

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

5. Saamya Biotech India Limited IPO - Close  Friday, September 28, 2007 12:00:00 AM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

6. Saamya Biotech India Limited IPO - Open  Tuesday, September 25, 2007 12:00:00 AM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

7. Saamya Biotech IPO opening on Sept 25  Tuesday, September 18, 2007 2:27:00 PM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
 
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Saamya Biotech IPO News & Events FAQs

The Saamya Biotech IPO is proposed to open on September 25, 2007. The IPO application ends on September 28, 2007.

Retail investors can apply in the retail or non-institutional investor category from September 25, 2007 to September 28, 2007. The Saamya Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Saamya Biotech IPO will open for subscription on September 25, 2007. The public issue will close on September 28, 2007.